A Phase 2, Randomized, Placebo-Controlled, Dose-Ranging Study Of PF-00489791 In Subjects With Stage 1 And 2 Essential Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM)
Phase of Trial: Phase II
Latest Information Update: 01 Jun 2009
At a glance
- Drugs PF 489791 (Primary)
- Indications Essential hypertension; Hypertension
- Focus Therapeutic Use
- 25 Feb 2008 Status change from in progress to completed, as reported by clinicaltrials.gov.
- 11 Jan 2008 Status change from recruiting to in progress.
- 28 Dec 2007 The expected completion date for this trial is now 1 Jan 2008.